Tamunal Sustained-Release Tablet 0.2 mg (Tamsulosin Hydrochloride)

Adult dose

Adults: Administer 0.2mg of tamsulosin hydrochloride orally once daily after a meal. Swallow this medicine whole; do not break or chew it. Adjust the dose as appropriate according to symptoms.

This medication should not be used in patients who are allergic to this medication or its components, or have a history of hypersensitivity reactions such as angioedema. Patients with orthostatic hypotension may experience worsening symptoms, so it is best to avoid administration. In patients with severely impaired liver function, blood concentration may increase, so use should be avoided. Pregnant women or women who may become pregnant should not take this medication. In elderly patients or those with severely impaired renal function, blood concentration may increase, so caution is advised. When taken with antihypertensive drugs or certain other medications, the risk of side effects may increase due to interactions, so careful administration is necessary. Particularly, when combined with antihypertensives or PDE5 inhibitors, there may be a risk of hypotension or orthostatic hypotension, requiring attention. Dizziness, drowsiness, headache, and other symptoms may occur during treatment, so care should be taken when driving or performing hazardous tasks. If there is a sudden drop in blood pressure or fainting, consult a doctor immediately. If allergic reactions such as skin rash, itching, or hives occur, discontinue use and inform medical personnel. Gastrointestinal symptoms such as dyspepsia, nausea, vomiting, constipation, or diarrhea may also occur, so caution is needed if symptoms arise. Liver function abnormalities or jaundice symptoms may occur, so liver function should be monitored periodically. In rare cases, prolonged erections may occur, which may require treatment, so consult medical personnel if symptoms persist. This medication is primarily used to treat benign prostatic hyperplasia, and if symptoms do not improve, other treatment options such as surgery should be considered. This medication is not recommended for pregnant or nursing women or children under 18, as safety has not been established. This medication is in sustained-release or capsule form, and should not be chewed or crushed, but taken with water. When taking, remove from the PTP packaging and take immediately; swallowing in the packaging may cause damage to the esophagus, so caution is necessary. Store out of reach of children and do not transfer to other containers.

Fainting, loss of consciousness, dizziness, disturbance of balance, orthostatic dizziness, headache, drowsiness, neurosensitivity, insomnia, decreased libido, anxiety, tingling sensation, tachycardia, low blood pressure, orthostatic hypotension, palpitations, arrhythmia, rash, itching, urticaria, nausea, vomiting, discomfort in the stomach, feelings of heaviness in the stomach, stomach pain, loss of appetite, thirst, constipation, diarrhea, dental disorders, swallowing disorders, elevated AST, elevated ALT, jaundice, burning sensation in the oropharynx, fatigue, nasal congestion, nosebleeds, edema, incontinence, taste disturbances, gynecomastia, priapism, infections, lethargy, back pain, chest pain, rhinitis, pharyngitis, increased cough, sinusitis, abnormal ejaculation, amblyopia, intraoperative pupillary tension reduction syndrome, blurred vision, visual impairment, erythema multiforme, exfoliative dermatitis, Stevens-Johnson syndrome, photosensitivity reactions, chest discomfort, dyspnea, sexual dysfunction, flushing, tinnitus, skin conditions of the tongue, lips, and facial areas, skin detachment

This medication should be stored in a tightly closed container to protect from air and moisture, and should be kept at room temperature between 1 to 30 degrees Celsius.

Appearance

A white round sustained-release tablet with pale yellow specks.

Package unit

30 tablets/box [10 tablets/PTP x 3]